Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth N Ross

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Molecular Cancer Therapeutics|December 6, 2015
AKT Inhibition Promotes Nonautonomous Cancer Cell SurvivalSalony, Xavier Solé, Cleidson P Alves, et al.
Blood|April 21, 2009
Identification of AML1-ETO modulators by chemical genomicsSteven M Corsello, Giovanni Roti, Kenneth N Ross, et al.
Cancer Cell|February 26, 2013
Complementary genomic screens identify SERCA as a therapeutic target in NOTCH1 mutated cancerGiovanni Roti, Anne Carlton, Kenneth N Ross, et al.
Nature Chemical Biology|March 15, 2016
Light-controlled modulation of gene expression by chemical optoepigenetic probesSurya A Reis, Balaram Ghosh, J Adam Hendricks, et al.
Cancer Cell|October 3, 2006
Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulatorsHaley Hieronymus, Justin Lamb, Kenneth N Ross, et al.
Oncotarget|September 18, 2014
Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastomaNathan F Moore, Anna M Azarova, Namrata Bhatnagar, et al.
Molecular Cancer Therapeutics|October 22, 2017
AKT1<sup>low</sup> Quiescent Cancer Cells Promote Solid Tumor GrowthCleidson P Alves, Ipsita Dey-Guha, Sheheryar Kabraji, et al.
Cell|May 17, 2016
SIRT6 Suppresses Pancreatic Cancer through Control of Lin28bSita Kugel, Carlos Sebastián, Julien Fitamant, et al.
Science Advances|February 18, 2020
Aneuploidy and a deregulated DNA damage response suggest haploinsufficiency in breast tissues of <i>BRCA2</i> mutation carriersMihriban Karaayvaz-Yildirim, Rebecca E Silberman, Adam Langenbucher, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2020
LIN28B regulates transcription and potentiates MYCN-induced neuroblastoma through binding to ZNF143 at target gene promotorsTing Tao, Hui Shi, Luca Mariani, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Molecular Cancer Therapeutics|December 6, 2015
AKT Inhibition Promotes Nonautonomous Cancer Cell SurvivalSalony, Xavier Solé, Cleidson P Alves, et al.
Blood|April 21, 2009
Identification of AML1-ETO modulators by chemical genomicsSteven M Corsello, Giovanni Roti, Kenneth N Ross, et al.
Cancer Cell|February 26, 2013
Complementary genomic screens identify SERCA as a therapeutic target in NOTCH1 mutated cancerGiovanni Roti, Anne Carlton, Kenneth N Ross, et al.
Nature Chemical Biology|March 15, 2016
Light-controlled modulation of gene expression by chemical optoepigenetic probesSurya A Reis, Balaram Ghosh, J Adam Hendricks, et al.
Cancer Cell|October 3, 2006
Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulatorsHaley Hieronymus, Justin Lamb, Kenneth N Ross, et al.
Oncotarget|September 18, 2014
Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastomaNathan F Moore, Anna M Azarova, Namrata Bhatnagar, et al.
Molecular Cancer Therapeutics|October 22, 2017
AKT1<sup>low</sup> Quiescent Cancer Cells Promote Solid Tumor GrowthCleidson P Alves, Ipsita Dey-Guha, Sheheryar Kabraji, et al.
Cell|May 17, 2016
SIRT6 Suppresses Pancreatic Cancer through Control of Lin28bSita Kugel, Carlos Sebastián, Julien Fitamant, et al.
Science Advances|February 18, 2020
Aneuploidy and a deregulated DNA damage response suggest haploinsufficiency in breast tissues of <i>BRCA2</i> mutation carriersMihriban Karaayvaz-Yildirim, Rebecca E Silberman, Adam Langenbucher, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2020
LIN28B regulates transcription and potentiates MYCN-induced neuroblastoma through binding to ZNF143 at target gene promotorsTing Tao, Hui Shi, Luca Mariani, et al.
Pageof 4